Retrospective study finds inverse association between NHHR and osteoporotic fracture risk

A retrospective cross-sectional cohort study examined the association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and osteoporotic fracture risk in 580 patients from the Department of Endocrinology at Gansu Provincial People's Hospital in China. The study measured NHHR as the exposure and assessed osteoporotic fracture as the primary outcome. No comparator group was explicitly reported.

The analysis revealed a significant inverse association between higher NHHR and lower odds of osteoporotic fracture, with an overall odds ratio (OR) of 0.55 (95% CI: 0.45–0.66, p < 0.001). A dose-response relationship was observed across NHHR quartiles, where patients in the highest quartile had substantially lower odds of fracture compared to those in the lowest quartile (OR = 0.20, 95% CI: 0.11–0.36, p < 0.001). Furthermore, the relationship was non-linear, with a statistically significant inflection point identified at an NHHR value of 3.29 (p for non-linearity < 0.001). Absolute numbers for fracture events were not reported.

Safety and tolerability data were not reported. The primary limitation is the retrospective, cross-sectional nature of the study design, which precludes establishing causality and may be susceptible to confounding. The findings represent an association, not causation, and their generalizability is limited to similar clinical settings. Further prospective, longitudinal investigations are needed to confirm this relationship and explore any potential mechanistic links before considering NHHR as a clinical marker for fracture risk assessment.

Researchers looked at whether a specific cholesterol measurement in the blood, called the non-HDL to HDL cholesterol ratio (NHHR), was linked to the risk of having an osteoporotic fracture. They studied 580 patients from the endocrinology department at a hospital in China. The study was retrospective, meaning it looked back at existing medical records, and cross-sectional, meaning it captured data at a single point in time.

The main finding was that patients with a higher NHHR had lower odds of having an osteoporotic fracture. The relationship followed a pattern where the highest levels of this ratio were linked to the lowest fracture odds. The analysis also suggested this link was not a straight line, but changed at a specific point.

No safety concerns were reported, as the study only measured cholesterol levels and did not involve any treatment. The main reason to be careful is the study's design. Because it looked at data from one moment and did not follow people over time, it can only show an association, not prove that the cholesterol ratio actually prevents fractures. Readers should view this as an early finding from one hospital's patient group that needs to be confirmed by different types of studies in broader populations.